Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
164.45
+1.04 (0.64%)
Aug 10, 2026, 3:12 PM EDT - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '13 Dec '12
INGREZZA Revenue
2.72B2.51B2.31B
CRENESSITY Revenue
570.30M301.20M1.70M
ONGENTYS and Other Product Revenue
-19.00M15.40M
Total Net Product Revenue
3.35B2.83B2.33B
Royalties Revenue
--18.60M
Collaboration and Other Revenue
--6.10M
Total Collaboration Revenue
20.40M26.60M24.70M
Revenue (Other)
-570.30M-301.20M-1.70M
Revenue (Total)
3.37B2.86B2.36B